Research Keyword: in vitro assay

Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials

mycolabadmin

This comprehensive review examines how medicinal mushrooms contain natural compounds that can boost immune function, fight cancer cells, reduce inflammation, and protect nerve cells. Different mushroom species like reishi, shiitake, and maitake contain various active substances such as beta-glucans and triterpenes that work through multiple biological pathways. While laboratory and animal studies show promising results, more human clinical trials are needed to confirm effectiveness and establish safe dosing guidelines.

Read More »

The Anticancer Potential of Edible Mushrooms: A Review of Selected Species from Roztocze, Poland

mycolabadmin

This review examines edible mushrooms found in Poland’s Roztocze region for their potential to fight cancer. These mushrooms contain natural compounds like polysaccharides and proteins that can kill cancer cells in laboratory studies through various mechanisms, including triggering cell death and boosting immune function. While promising, these findings from laboratory and animal studies need further development before becoming clinical treatments.

Read More »

Inhibition of Fusarium oxysporum growth in banana by silver nanoparticles: In vitro and in vivo assays

mycolabadmin

Researchers tested silver nanoparticles as a potential cure for Fusarium wilt, a serious fungal disease that damages banana crops worldwide. Using laboratory tests and greenhouse experiments with banana plants, they found that silver nanoparticles effectively killed the fungus and reduced disease symptoms by about 68% when applied to plant roots. The study shows that this nanotechnology approach could offer a new way to protect banana plantations from this devastating disease.

Read More »

Taxonomic characterization and cytotoxic potential of Vietnamese Ganoderma ellipsoideum against human breast cancer MCF-7 cells

mycolabadmin

Scientists discovered a mushroom species called Ganoderma ellipsoideum in Vietnam that shows promise in fighting breast cancer. When tested on cancer cells in the laboratory, extracts from this mushroom killed cancer cells effectively. Computer modeling showed that compounds from this mushroom fit perfectly into and block proteins that help cancer cells grow and spread. This discovery suggests the mushroom could be a natural source for developing new cancer drugs.

Read More »

Investigation of the In Vitro Antioxidant, Anticholinesterase, Antiurease, Antityrosinase, and Cytotoxic Properties of a Novel Compound: 4-Methoxy-2-(4-Methoxyphenyl)Benzo[d][1,3,2]Dioxaborole

mycolabadmin

Scientists created a new chemical compound containing boron that showed promise as a potential medicine. The compound was effective at neutralizing harmful molecules in cells and inhibiting enzymes related to Alzheimer’s disease. Importantly, it did not damage healthy cells or kill cancer cells, suggesting it could be safe for future medical applications in treating various diseases.

Read More »

Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau

mycolabadmin

Researchers tested extracts from traditional Tibetan medicinal plants, mushrooms, and lichens to see if they could fight influenza virus. They found that seven out of nine extracts could reduce influenza virus infection in laboratory cells, with a mushroom extract called Armillaria luteo-virens showing particularly strong antiviral effects. These results suggest that traditional medicinal materials from the Qinghai–Tibetan plateau could be valuable sources for developing new flu treatments that might work better against drug-resistant flu strains.

Read More »
Scroll to Top